Skip to content

Evolent Health, Inc. EVH Other long-term liabilities

Other long-term liabilities at other companies

The Oncology Institute, Inc. logo
The Oncology Institute, Inc.TOI
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
Centene logo
CenteneCNC

Other financials

Income statement

See full
Revenue$496.2M+2.6%
Gross profit$83.8M-18.2%
Operating income-$10.6M-553%
Net income-$26.6M+58.8%
EPS (diluted)-$0.24+61.9%

Balance sheet

See full
Cash & equivalents$142.0M-42.4%
Total debt$985.4M+13.3%
Total equity$396.4M-57.6%
Total assets$1.9B-29.2%

Cash flow

See full
Operating cash flow-$984.0K-122%

Valuation

See full
Market cap$565.78M-47.9%
Enterprise value$1.41B-17.6%
P/S0.3×-0.2×

Profitability

See full
Gross margin20.2%+4.9pp
Operating margin-22.2%-23.5pp
Net margin-26.3%-33.2pp
FCF margin-9.7%

Returns & leverage

See full
Return on equity-74.6%-90.1pp
Debt / equity2.5×+1.6×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by Evolent Health, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evolent Health, Inc.'s other long-term liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evolent Health, Inc.'s other long-term liabilities?
Evolent Health, Inc. (EVH) reported other long-term liabilities of $79K in Q1 2026.
How has Evolent Health, Inc.'s other long-term liabilities changed year-over-year?
Evolent Health, Inc.'s other long-term liabilities decreased by 72.3% year-over-year, from $285K to $79K.
What is the long-term trend for Evolent Health, Inc.'s other long-term liabilities?
Over 3 years (2022 to 2025), Evolent Health, Inc.'s other long-term liabilities has grown at a 43.4% compound annual growth rate (CAGR), from -$1.71M to $5.03M.